Get ready for a slew of diabetes news announcements, because the ADA’s huge annual conference starts today!
I’ll be on an airplane pretty much all day (Friday) heading out to Orlando to cover this conference live, although I must warn you: it’s quite overwhelming. Running around the 450,000 square-foot convention center trying to see every diabetes company represented in the enormous exhibit halls while hundreds of symposia and other talk sessions are happening simultaneously is…
Read more »
People are doing amazing things to raise awareness for diabetes. So much so that I can barely keep up with all the notifications I get on fabulous initiatives and projects. This post is the first of a two-part dispatch on some of this stuff, which — if you care about diabetes or someone who has it — you will definitely want to know about.
Connect for the Cure
Tira J. Young, a portrait photographer based…
Read more »
I’ve been as vocal as anyone complaining about the lack of solid diabetes data reporting in this country, and how that hampers our cause on many levels. Now D-community leader Manny Hernandez and his wonderful crew at the non-profit Diabetes Hands Foundation are taking this problem into their own hands, so to speak. They’ve struck up a partnership to launch a remarkable new reporting application. To explain it all, I’ve asked Manny to join us…
Read more »
By
AmyT on
April 16, 2010
If you can still get excited about diabetes research headlines, then here’s some exciting news coming out of Cambridge, Mass, this week: Tolerx, a life sciences company, has reported they are in Phase 3 clinical trials for a new treatment of type 1 diabetes. If everything goes to plan, a representative of the company says, Tolerx could launch the first-ever offering approved by the FDA to treat the cause of type 1 diabetes. Pretty cool!…
Read more »
The high-powered diabetic cycling group Team Type 1 has once again pulled off a jaw-dropping feat: they’ve somehow caught the attention of 23andMe, one of just three celeb-status companies in the world offering “personal genomics services” — they scan people’s DNA for details on their ancestry and individual health risks — and convinced them to launch a probe into Type 1 and Type 2 diabetes.
This research could provide unprecedented insights into the genes that…
Read more »
